BioPharma Dive March 4, 2024
Meg Richards, PhD, MBH Executive Director of Solutions, Panalgo With Mike Munsell, Director of Research, Panalgo

Sponsored content By Panalgo

In a rapidly evolving landscape where artificial intelligence (AI) and machine learning (ML) have become household terms, their impact on biopharmaceutical research and epidemiology is profound. I caught up with Mike Munsell, PhD, Director of Research at Panalgo, to discuss how these technologies are transforming the healthcare research landscape and their real-world applications in biopharmaceutical R&D. Classically trained epidemiologists know more about ML and AI than they think they do, and here’s why.

Q: We’re hearing more about AI, ML, and ChatGPT these days. Can you give me a definition of what each is and how they might overlap?

A: With AI, computers are essentially mimicking human decision-making. ML, a subdiscipline of AI, uses algorithms...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Interview / Q&A, Pharma, Pharma / Biotech, Technology, Trends
Regulations, Innovations and AI Define This Week in Big Tech
Why health system AI predictions can fail
10 things you may have suspected about AI but didn’t know for sure till now
Meta's new AI assistant is rolling out across WhatsApp, Instagram, Facebook and Messenger
Exclusive: Powerful new AI model accurately converts speech to text, even your company's jargon

Share This Article